REGISTERED NUMBER: 16160262 (England and Wales)

Unaudited Financial Statements for the Period 2 January 2025 to 31 January 2026

for

Biologics Consulting Ltd

Page

Balance Sheet

1

FIXED ASSETS

925

CURRENT ASSETS

25,271

CREDITORS

Amounts falling due within one year

(22,998

)

NET CURRENT ASSETS

2,273

TOTAL ASSETS LESS CURRENT LIABILITIES

3,198

CAPITAL AND RESERVES

3,198

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Biologics Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

16160262

Registered office:

Suite 175 182-184 High Street North

Area 1/1, East Ham

London

E6 2JA

The presentation currency of the financial statements is the Pound Sterling (£).

2.	PERIOD OF ACCOUNTS AND COMPARATIVE AMOUNTS

Biologics Consulting LTD was incorporated in England and Wales on 2 January 2025 and has an accounting reference period set to 31 January.

The accounts presented cover the 395 day period from 2 January 2025 to 31 January 2026.

As this is the first period of trading no comparative amounts are relevant

3.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 2 .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2026 and were signed on its behalf by:

A Patel - Director